Mast Cell Activation Syndrome (MCAS) – Symptoms & Treatment
Mast Cell Activation Syndrome (MCAS) is a chronic immune disorder in which mast cells are repeatedly and excessively activated, releasing inflammatory mediators that trigger a wide range of symptoms.
Wissenswertes über "Mast Cell Activation Syndrome"
Mast Cell Activation Syndrome (MCAS) is a chronic immune disorder in which mast cells are repeatedly and excessively activated, releasing inflammatory mediators that trigger a wide range of symptoms.
What Is Mast Cell Activation Syndrome?
Mast Cell Activation Syndrome (abbreviated MCAS) is a chronic condition of the immune system in which specialized immune cells called mast cells become repeatedly and inappropriately activated. Mast cells are found in virtually every tissue in the body and play a key role in immune defense and allergic responses. In MCAS, these cells release excessive amounts of chemical messengers known as mediators -- including histamine, tryptase, and prostaglandins -- causing a wide variety of symptoms across multiple organ systems.
Causes
The exact causes of MCAS are not yet fully understood. Three main subtypes are recognized:
- Primary MCAS: Caused by clonal proliferation of mast cells, as seen in mastocytosis or certain hematological disorders.
- Secondary MCAS: Mast cells are activated by an underlying condition such as allergies, chronic infections, or autoimmune diseases.
- Idiopathic MCAS: No identifiable cause is found; mast cells react excessively without a clear external trigger.
Common triggers for mast cell activation include stress, heat, cold, certain foods, medications, physical exertion, and infections.
Symptoms
MCAS is characterized by a remarkably diverse range of symptoms. Because mast cells are present in nearly all organs, complaints can arise throughout the entire body:
- Skin: Flushing, itching, hives (urticaria), wheals
- Gastrointestinal tract: Abdominal pain, nausea, vomiting, diarrhea, bloating
- Respiratory system: Shortness of breath, coughing, nasal congestion or runny nose
- Cardiovascular system: Rapid heartbeat (tachycardia), low blood pressure, dizziness, or fainting
- Neurological symptoms: Difficulty concentrating (often called brain fog), headaches, fatigue
- Muscle and joint pain
In severe cases, MCAS can trigger an anaphylactic reaction, which constitutes a medical emergency requiring immediate treatment.
Diagnosis
Diagnosing MCAS can be challenging due to its non-specific and highly variable symptoms. Diagnosis typically requires meeting three criteria:
- Characteristic symptoms: Recurrent complaints affecting multiple organ systems.
- Laboratory evidence: Elevated mast cell mediators in blood or urine, particularly tryptase, histamine, or its metabolites (e.g., methylhistamine in urine).
- Response to therapy: Improvement of symptoms following treatment with medications that inhibit mast cells or their mediators (e.g., antihistamines).
In cases where primary mastocytosis is suspected, additional investigations such as bone marrow biopsy or specific genetic testing (e.g., KIT D816V mutation) may be performed.
Treatment
There is currently no cure for MCAS. Treatment focuses on controlling symptoms and avoiding known triggers.
Pharmacological Treatment
- Antihistamines (H1 and H2 blockers): Block the effects of histamine at target receptors and form the cornerstone of MCAS management.
- Mast cell stabilizers: Agents such as cromolyn sodium prevent the release of mediators from mast cells.
- Leukotriene antagonists: Inhibit another class of inflammatory signaling molecules.
- Corticosteroids: Used short-term during severe episodes.
- Epinephrine auto-injector: Prescribed for patients at risk of anaphylaxis as an emergency intervention.
Non-Pharmacological Measures
- Keeping a symptom diary to identify individual triggers
- Dietary adjustments (e.g., low-histamine diet)
- Stress management and consistent avoidance of known triggers
References
- Valent P. et al. - Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal. International Archives of Allergy and Immunology, 2012.
- Akin C. - Mast cell activation syndromes. Journal of Allergy and Clinical Immunology, 2017.
- Molderings G.J. et al. - Mast cell disease: a comprehensive introduction. Leukemia and Lymphoma, 2011.
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCalcium Ionophore
Urine Biomarkers
Patellofemoral Syndrome
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Cologne list
Calorie content
Related search terms: Mast Cell Activation Syndrome + Mast Cell Activation Disorder + MCAS + MCAD